Literature DB >> 7438047

Diminished hepatic binding protein for desialylated glycoproteins during chemical hepatocarcinogenesis.

R J Stockert, F F Becker.   

Abstract

The lectin hepatic binding protein has a specific binding capacity for desialylated serum glycoproteins and is limited to hepatocyte membranes. This binding capacity was reduced by approximately 60% in the neoplastic nodules which resulted from exposure of rat livers to N-2-acetylaminofluorene. The binding capacity of the primary hepatocellular carcinomas which resulted from this regimen was reduced by 95%. The loss of binding capacity was found to be proportional to the decreased concentration of immunologically detectable lectin in the altered tissues.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438047

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Transformation-associated decrease in cell surface binding of neoglycoenzymes in a temperature-sensitive, virally transformed mouse model.

Authors:  H J Gabius; S Gabius; M Fritsche; G Brandner
Journal:  Naturwissenschaften       Date:  1991-05

2.  Targeted protection of hepatocytes from galactosamine toxicity in vivo.

Authors:  V Keegan-Rogers; G Y Wu
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  A role of asialoglycoproteins for plasma-membrane-induced inhibition of the switching from alpha 1 to beta subtypes in adrenergic response during primary culture of rat hepatocytes.

Authors:  Y Kajiyama; Y Sanai; M Ui
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

4.  99mTc-neoglycoalbumin (NGA)-binding to human hepatic binding protein (HBP) in vitro.

Authors:  I Virgolini; P Angelberger; C Müller; J O'Grady; H Sinzinger
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

5.  [Approaches to a selective chemotherapy of hepatocellular carcinoma (author's transl)].

Authors:  J Pausch; A Holstege; D Keppler; W Gerok
Journal:  Klin Wochenschr       Date:  1981-06-15

6.  Serum levels of c-erbB-2 protein in digestive diseases.

Authors:  Y Motoo; N Sawabu; Y Yamaguchi; I Mouri; O Yamakawa; H Watanabe; H Ohta; T Okai; H Makino
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

7.  Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.

Authors:  I Virgolini; C Müller; W Klepetko; P Angelberger; H Bergmann; J O'Grady; H Sinzinger
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

8.  Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.

Authors:  I Virgolini; G Kornek; J Höbart; S R Li; M Raolerer; H Bergmann; W Scheithauer; T Pantev; P Angelberger; H Sinzinger
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

9.  Targeted transplantation of mitochondria to hepatocytes.

Authors:  Nidhi Gupta; Catherine H Wu; George Y Wu
Journal:  Hepat Med       Date:  2016-11-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.